Table 2.
Demographic and clinical features of the patients with mastocytosis.
| Demographic and clinical features of patients (n = 60) | |
|---|---|
| Age (years, mean ± SD) | 43.60 ± 9.90 |
| Gender | |
| Female (n,%) | 34 (56.7%) |
| Male (n,%) | 26 (43.3%) |
| Smokers (n,%) | 38 (63.3%) |
| Alcohol consumption (n,%) | 10 (16.7%) |
| Education | |
| Not going to school (n,%) | 4 (6.7%) |
| Primary school (n,%) | 14 (23.3%) |
| High school (n,%) | 21 (35%) |
| University (n,%) | 21 (35%) |
| Working status (n,%) | |
| Active work (n,%) | 7 (11.7%) |
| Flexible work (n,%) | 23 (38.3%) |
| Housewife (n,%) | 19 (31.7%) |
| Salary without work (n,%) | 6 (10%) |
| Retired (n,%) | 3 (5%) |
| Fired (n,%) | 2 (2%) |
| Comorbid diseases | |
| Diabetes mellitus (n,%) | 9 (15%) |
| Hypertension (n,%) | 13 (21.7%) |
| Hyperlipidemia (n,%) | 4 (6.7%) |
| Hypothyroidism (n,%) | 3 (5%) |
| Malignancy (n,%) | 2 (3.3%) |
| Type of mastocytosis | |
| CM (n,%) | 5 (8.3%) |
| ISM (n,%) | 50 (83.3%) |
| AdvSM (n,%) | 5 (8.3%) |
| Duration of disease (years, mean ± SD) | 6.27 ± 4.91 |
| Serum baseline tryptase level (kU/L), (median, IQR25-75) | 25.7 (12.65–38.55) |
| Regular visit to hospital for follow-up in LP (n,%) | 6 (10%) |
| Regular visit to hospital for follow-up in RTNP (n,%) | 34 (56.7%) |
AdvSM, Advanced systemic mastocytosis; CM, Cutaneous mastocytosis; FCV-19S, Fear of COVID-19 scale; ISM, Indolent systemic mastocytosis; LP, Lockdown period; RTNP, Return to Normal period; SD, Standart deviation.